Berupipam (hemifumarate)
Berupipam hemifumarate is a selective antagonist of the dopamine D1 receptor (dopamine D1 receptor) . Berupipam hemifumarate is a substrate of UDP-glucuronosyltransferase (UGT) and has a high affinity for UGT enzymes but a relatively low conversion rate. The glucuronidation rate of Berupipam hemifumarate varies among different species and genders. Berupipam hemifumarate can be used for the study of psychotic disorders[1].
Product Specifications
CAS Number
[172940-14-6]
UNSPSC
12352005
Target
Dopamine Receptor; UGT
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
CN1C[C@H](C2=C3C(CCO3)=CC(Br)=C2)C4=CC(O)=C(Cl)C=C4CC1.OC(/C=C/C(O)=O)=O.[1/2]
Molecular Formula
C23H23BrClNO6
Molecular Weight
524.79
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Bovine Ubiquitin-Like With PHD And Ring Finger Domains 1 ELISA Kit
Bovine Ubiquitin-Like With PHD And Ring Finger Domains 1 ELISA Kit
Bovine Ubiquitin-Like With PHD And Ring Finger Domains 1 ELISA Kit
Bovine Ubiquitin-Like With PHD And Ring Finger Domains 1 ELISA Kit